HK1213496A1 - 種用於治療乙型病毒性肝炎的 組合物 - Google Patents

種用於治療乙型病毒性肝炎的 組合物

Info

Publication number
HK1213496A1
HK1213496A1 HK16101640.4A HK16101640A HK1213496A1 HK 1213496 A1 HK1213496 A1 HK 1213496A1 HK 16101640 A HK16101640 A HK 16101640A HK 1213496 A1 HK1213496 A1 HK 1213496A1
Authority
HK
Hong Kong
Prior art keywords
sirna
viral hepatitis
treating viral
composition
sirna composition
Prior art date
Application number
HK16101640.4A
Other languages
English (en)
Inventor
崔坤元
梁東
Original Assignee
廈門成坤生物技術有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 廈門成坤生物技術有限公司 filed Critical 廈門成坤生物技術有限公司
Publication of HK1213496A1 publication Critical patent/HK1213496A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK16101640.4A 2015-05-28 2016-02-16 種用於治療乙型病毒性肝炎的 組合物 HK1213496A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510282415.7A CN104922141B (zh) 2015-05-28 2015-05-28 一种用于治疗乙型病毒性肝炎的siRNA组合物

Publications (1)

Publication Number Publication Date
HK1213496A1 true HK1213496A1 (zh) 2016-07-08

Family

ID=54109798

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16101640.4A HK1213496A1 (zh) 2015-05-28 2016-02-16 種用於治療乙型病毒性肝炎的 組合物

Country Status (3)

Country Link
CN (1) CN104922141B (zh)
HK (1) HK1213496A1 (zh)
WO (1) WO2016188473A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104922141B (zh) * 2015-05-28 2016-05-25 厦门成坤生物技术有限公司 一种用于治疗乙型病毒性肝炎的siRNA组合物
CN107827762B (zh) * 2017-11-14 2020-10-02 苏州东南药业股份有限公司 一种(2,3-二油酰基-丙基)三甲基氯化铵及其制备方法和用途
WO2019105419A1 (zh) 2017-12-01 2019-06-06 苏州瑞博生物技术有限公司 一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
CN110945131B (zh) * 2017-12-01 2024-05-28 苏州瑞博生物技术股份有限公司 一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
CA3083968C (en) 2017-12-01 2024-04-23 Suzhou Ribo Life Science Co., Ltd. Double-stranded oligonucleotide, composition and conjugate comprising double-stranded oligonucleotide, preparation method thereof and use thereof
US11633482B2 (en) 2017-12-29 2023-04-25 Suzhou Ribo Life Science Co., Ltd. Conjugates and preparation and use thereof
WO2020038377A1 (zh) 2018-08-21 2020-02-27 苏州瑞博生物技术有限公司 一种核酸、含有该核酸的药物组合物和缀合物及其用途
JP7376952B2 (ja) 2018-09-30 2023-11-09 スーチョウ リボ ライフ サイエンス カンパニー、リミテッド ｓｉＲＮＡ複合体及びその調製方法と使用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1648519B1 (en) * 2003-07-16 2014-10-08 Protiva Biotherapeutics Inc. Lipid encapsulated interfering rna
WO2010135207A1 (en) * 2009-05-16 2010-11-25 Agave Pharma, Incorporated Compositions comprising cationic amphiphiles and colipids for delivering therapeutics molecules
US20110200582A1 (en) * 2009-12-23 2011-08-18 Novartis Ag Lipids, lipid compositions, and methods of using them
JP6124078B2 (ja) * 2010-08-26 2017-05-10 ツイ，クンユァン 巨大環状脂肪族化合物及びその応用
CN104107437B (zh) * 2013-06-09 2015-08-26 厦门成坤生物技术有限公司 一种用于治疗乙型病毒性肝炎的rna干扰组合物及其制备方法
CN104922141B (zh) * 2015-05-28 2016-05-25 厦门成坤生物技术有限公司 一种用于治疗乙型病毒性肝炎的siRNA组合物
CN104940952B (zh) * 2015-05-29 2016-05-25 厦门成坤生物技术有限公司 包含大环酯类化合物和siRNA的组合物及其制备方法

Also Published As

Publication number Publication date
WO2016188473A1 (zh) 2016-12-01
CN104922141B (zh) 2016-05-25
CN104922141A (zh) 2015-09-23

Similar Documents

Publication Publication Date Title
IL280459A (en) Phosphoramidates for the treatment of hepatitis B virus
IL264575A (en) RNA materials for hepatitis b virus infection
HK1258795A1 (zh) 絲狀病毒科病毒感染的治療方法
HK1246347A1 (zh) 修飾的肝炎轉錄後調節元件
IL282881A (en) Methods for treating hepatitis B infection
HK1213496A1 (zh) 種用於治療乙型病毒性肝炎的 組合物
HK1249046A1 (zh) 治療b型肝炎病毒的方法
HK1255481A1 (zh) 用於治療hcv的方法
SI3250550T1 (sl) Sestave in metode za senzibilizacijo virusov
PL3131890T3 (pl) Związki do leczenia zakażeń wirusowych
GB201522013D0 (en) Virus
GB201516936D0 (en) Virus
GB201507419D0 (en) Virus

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200531